mtDNA regulates cGAS-STING signaling pathway in adenomyosis

Free Radic Biol Med. 2024 Apr:216:80-88. doi: 10.1016/j.freeradbiomed.2024.03.012. Epub 2024 Mar 15.

Abstract

In various hyperproliferative disorders, damaged mitochondria can release mitochondrial DNA (mtDNA) into the cytoplasm, activating the cGAS-STING signaling pathway and subsequent immune imbalances. Our previous research has demonstrated that hypoxia plays a role in the development of adenomyosis (AM) by inducing mitochondrial dysfunction. However, the precise involvement of the cGAS-STING signaling pathway and mtDNA in AM remains unclear. Therefore, this study aims to investigate the relationship between mtDNA secretion, changes in the cGAS-STING signaling pathway, and the abnormal cellular proliferation observed in AM. We found the cGAS, STING, TBK1, p-TBK1, IRF3, and p-IRF3 proteins levels were significantly elevated in the tissues of patients with AM compared to the control group. Additionally, there was an increase in the expression of the pro-inflammatory cytokines IL-6 and IFN-α in the AM tissues. Hypoxia-induced an increase in the proliferation and migration abilities of endometrial stromal cells (ESCs), accompanied by the activation of the cGAS-STING signaling pathway and elevated levels of IFN-α. Furthermore, hypoxia promoted the leakage of mtDNA into the cytoplasm in AM ESCs, and the deletion of mtDNA reduced the activation of the cGAS-STING pathway. Moreover, knockdown of the STING gene inhibited the expression of TBK1, p-TBK1, IRF3, and p-IRF3 and suppressed the secretion of the inflammatory cytokines IL-6 and IFN-α. Furthermore, the migration and invasion abilities of AM ESCs were significantly diminished after STING knockdown. These findings provide valuable insights into the role of mtDNA release and the cGAS-STING signaling pathway in the pathogenesis of AM.

Keywords: Adenomyosis; cGAS-STING signaling; mtDNA.

MeSH terms

  • Adenomyosis* / metabolism
  • Adenomyosis* / pathology
  • Cytokines / metabolism
  • DNA, Mitochondrial* / genetics
  • DNA, Mitochondrial* / metabolism
  • Female
  • Humans
  • Hypoxia / metabolism
  • Interleukin-6 / metabolism
  • Mitochondria / metabolism
  • Nucleotidyltransferases / genetics
  • Nucleotidyltransferases / metabolism
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism
  • Signal Transduction

Substances

  • Cytokines
  • DNA, Mitochondrial
  • Interleukin-6
  • Nucleotidyltransferases
  • Protein Serine-Threonine Kinases
  • STING1 protein, human